Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
President & COO
-
Stock Symbol
-
LGND on Nasdaq, LGNDZ, LGNXZ, LGNYZ, LGNZZ on OTC
Matthew E. Korenberg - trading volume in the past year for Ligand Pharmaceuticals Inc
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
50.8K |
$5.18M |
$102.05 |
Sep 23, 2024 |
Direct |
|
|
| Employee Stock Option (right to buy) |
58.5K |
|
|
Feb 27, 2024 |
Direct |
Common Stock |
|
| Employee Stock Option (right to buy) |
42.4K |
|
|
Sep 23, 2024 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.